Translational Safety Biomarker Pipeline: Enabling development and implementation of novel safety biomarkers in clinical trials and diagnosis of disease
We're excited to announce that Sophia Samodelov, our Project Coordinator, will be a panelist at the upcoming “Advancing regulatory science research” event organised by @EMA on November 18!
Register by November 13
👉 ema.europa.eu/en/events/adva…#biomarkers#H2020@IHIEurope
During last Cutting Edge Pathology Congress, Warren Glaab presented the results of nonclinical studies to support identification and qualification of biomarkers for early DINI
#IHICarryTheTorch#H2020#EUHealthResearch@IHIEurope